✦ LIBER ✦

Statins and Renal Disease: Friend or Foe?

✍ Scribed by Abhishek Deshmukh; Jawahar L. Mehta

Publisher: Current Science Inc.
Year: 2010
Tongue: English
Weight: 138 KB
Volume: 13
Category: Article
ISSN: 1523-3804
DOI: 10.1007/s11883-010-0140-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Statins and hepatitis C virus: Friend or

Statins and hepatitis C virus: Friend or foe?

✍ Enzo Emanuele 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB

Moreover, the combination of pitavastatin, AR, and interferon alfa was overwhelmingly more effective, compared with the previous results for the combination treatment of interferon alfa with ribavirin 3 or the combination treatment of interferon alfa plus fluvastatin. 4 In particular, we could decre

Therapist: Friend or Foe?

✍ Pia Charpentier 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 1 views

Oncostatin M: Foe or friend?

✍ Jean-Pierre Pelletier; Johanne Martel-Pelletier 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Cannabinoids and Bone: Friend or Foe?

✍ Aymen I. Idris; Stuart H. Ralston 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 397 KB

Statins and progressive renal disease

✍ Michele Buemi; Massimino Senatore; Francesco Corica; Carmela Aloisi; Adolfo Rome 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

## Abstract Thanks to the administration of hypocholesterolemic drugs, important advances have been made in the treatment of patients with progressive renal disease. __In vitro__ and __in vivo__ findings demonstrate that statins, the inhibitors of HMG‐CoA reductase, can provide protection against k

FRET and FCS—Friends or Foes?

✍ Dr. Harekrushna Sahoo; Prof. Petra Schwille 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 1 views